POC Medical Systems Inc.

The company's core technology is the Pandora CDx™ Point-of-Care System, a microfluidic platform designed for rapid serum screening. This system functions as a portable "lab-in-a-box," using a low-cost, disposable microfluidic compact disc to conduct tests. The process is automated, using centrifugal force to separate reagents after a blood sample is introduced, with an optical system detecting and measuring the concentration of specific analytes. The platform is designed to be operated by non-medical personnel with minimal training and can process multiple patients simultaneously. Test data is stored on a mobile tablet and uploaded to the cloud, allowing remote access for healthcare professionals.

The first product launched on this platform was the MammoAlert™ test, a blood-based screening tool for breast cancer. Requiring only a few drops of blood from a finger prick, the test analyzes multiple cancer biomarkers to generate a result in approximately 30 minutes. This multiplexed immunoassay was developed to offer a more accessible and affordable pre-screening alternative to mammograms, especially in regions with limited healthcare infrastructure. The business model appears to be based on the sale of the Pandora CDx™ instruments and the disposable, single-use MammoAlert™ test discs.